These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

210 related items for PubMed ID: 1731512

  • 1. Anagrelide, a therapy for thrombocythemic states: experience in 577 patients. Anagrelide Study Group.
    Am J Med; 1992 Jan; 92(1):69-76. PubMed ID: 1731512
    [Abstract] [Full Text] [Related]

  • 2. Anagrelide: a new drug for treating thrombocytosis.
    Silverstein MN, Petitt RM, Solberg LA, Fleming JS, Knight RC, Schacter LP.
    N Engl J Med; 1988 May 19; 318(20):1292-4. PubMed ID: 3362187
    [Abstract] [Full Text] [Related]

  • 3. [Treatment outcome of patients with essential thrombocythemia at our department in Hungary].
    Iványi JL, Marton É, Plander M, Szendrei T.
    Orv Hetil; 2016 Feb 28; 157(9):336-41. PubMed ID: 26895801
    [Abstract] [Full Text] [Related]

  • 4. Adverse effects and benefits of two years of anagrelide treatment for thrombocythemia in chronic myeloproliferative disorders.
    Birgegård G, Björkholm M, Kutti J, Lärfars G, Löfvenberg E, Markevärn B, Merup M, Palmblad J, Mauritzson N, Westin J, Samuelsson J.
    Haematologica; 2004 May 28; 89(5):520-7. PubMed ID: 15136214
    [Abstract] [Full Text] [Related]

  • 5. [Anagrelide in control of myeloproliferative thrombocythemia: long-term experiences in 6 patients].
    Burkhard R, Adam H, Widmer L, Honegger HP.
    Schweiz Med Wochenschr; 1998 Nov 14; 128(46):1808-12. PubMed ID: 9857387
    [Abstract] [Full Text] [Related]

  • 6. Anagrelide for thrombocytosis in myeloproliferative disorders: a prospective study to assess efficacy and adverse event profile.
    Steurer M, Gastl G, Jedrzejczak WW, Pytlik R, Lin W, Schlögl E, Gisslinger H.
    Cancer; 2004 Nov 15; 101(10):2239-46. PubMed ID: 15476273
    [Abstract] [Full Text] [Related]

  • 7. Role of anagrelide in the treatment of thrombocytosis.
    Brooks WG, Stanley DD, Goode JV.
    Ann Pharmacother; 1999 Oct 15; 33(10):1116-8, 1121. PubMed ID: 10534225
    [Abstract] [Full Text] [Related]

  • 8. Anagrelide is effective in treating patients with hydroxyurea-resistant thrombocytosis in patients with chronic myeloid leukemia.
    Silver RT.
    Leukemia; 2005 Jan 15; 19(1):39-43. PubMed ID: 15510207
    [Abstract] [Full Text] [Related]

  • 9. Anagrelide: 20 years later.
    Emadi A, Spivak JL.
    Expert Rev Anticancer Ther; 2009 Jan 15; 9(1):37-50. PubMed ID: 19105705
    [Abstract] [Full Text] [Related]

  • 10. Pharmacokinetics, bioequivalence, tolerability, and effects on platelet counts of two formulations of anagrelide in healthy volunteers and patients with thrombocythemia associated with chronic myeloproliferation.
    Petrides PE, Gisslinger H, Steurer M, Linkesch W, Krumpl G, Schüller A, Widmann R.
    Clin Ther; 2009 Feb 15; 31(2):386-98. PubMed ID: 19302911
    [Abstract] [Full Text] [Related]

  • 11. Anagrelide: analysis of long-term efficacy, safety and leukemogenic potential in myeloproliferative disorders.
    Fruchtman SM, Petitt RM, Gilbert HS, Fiddler G, Lyne A, Anagrelide Study Group.
    Leuk Res; 2005 May 15; 29(5):481-91. PubMed ID: 15755500
    [Abstract] [Full Text] [Related]

  • 12. Effectiveness of anagrelide in the treatment of symptomatic patients with essential thrombocythemia.
    Laguna MS, Kornblihtt LI, Marta RF, Michiels JJ, Molinas FC.
    Clin Appl Thromb Hemost; 2000 Jul 15; 6(3):157-61. PubMed ID: 10898276
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Anagrelide in the treatment of essential thrombocythemia (ET) and other myeloproliferative disorders with thrombocythemia based on data from patient register in the CR].
    Penka M, Doubek M, Schwarz J, Pytlík R, Dulícek P, Kissová J, Hlusí A, Vozobulová V, Cerná O, Brychtová Y, Szotkowski T, Volková Z, Seghetová J, Schutzová M, Hadacová I, Hochová I, Voglová J, Siroký O, Belada D, Lhot'anová T, Bubeník B, Vránová M, Micaníková M, Dusek L.
    Vnitr Lek; 2006 May 15; 52(5):498-503. PubMed ID: 16771099
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Thrombocytosis--report of a case.
    Thomas M, Pavithran K, Salil, Somarajan A.
    J Assoc Physicians India; 2000 Apr 15; 48(4):441-2. PubMed ID: 11273186
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.